Title of Invention

"SILYLATED CARBOXAMIDES"

Abstract Novel silylated carboxamides of the formula (I) in which R, L, R1, R2, R3, R4 and A are as defined in the description, a plurality of processes for preparing these compounds and their use for controlling unwanted microorganisms.
Full Text Silylated carboxamides
The present invention relates to novel silylated carboxamides, to a plurality of processes for their preparation and for their use for controlling unwanted microorganisms.
It is already known that numerous carboxamides have fungicidal properties (cf., for example, WO 03/080628, WO 03/010149, EP-A 0 589 301, EP-A 0 545 099). The activity of these compounds is good; however, it is sometimes, for example at low application rates, unsatisfactory.
This invention now provides novel silylated carboxamides of the formula (I)

(Figure Removed) R represents hydrogen, fluorine, chlorine,methyl, isopropyl, methylthio or trifluoromethyl,
L represents a direct bond or represents in each case optionally substituted straight-chain or
branched alkylene (alkanediyl), alkenylene (alkenediyl) or alkynylene (alkyndiyl),
R1 and R2 independently of one another represent hydrogen, Ci-C8-alkyl, CrC8-alkoxy, CrC4-aIkoxy-Ci-C4-alkyl, CrC4-alkylthio-C,-C4-alkyl or CrC6-haloalkyl,
R3 represents hydrogen, Ci-Cg-alkyl, Ci-C8-alkoxy, Ci-C4-alkoxy-Ci-C4-alkyl, Ci-C4-alkylthio-CrC4-alkyl, C2-C8-alkenyl, C2-C8-alkynyl, CrC6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C6-cycloalkyl, or represents in each case optionally substituted phenyl or phenylalkyl,
R4 represents hydrogen, Ci-Cg-alkyl, Ci-C6-alkylsulphinyl, Ci-Ce-alkylsulphonyl, Cj-Q-alkoxy-d-C4-alkyl, C3-C8-cycloalkyl; CrC6-haloalkyl, CrC4-haloalkylthio, CrC4-haloalkylsulphinyl, Ci-C4-haloalkylsulphonyl, halo-Ci-C4-alkoxy-Ci-C4-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; formyl, formyl-C,-C3-alkyl, (CrC3-alkyl)carbonyl-CrC3-alkyl, (CrC3-alkoxy)carbonyl-C,-C3-alkyl; halo-(CrC3-alkyl)carbonyl-C|-C3-alkyl, halo^Ci-Cralkoxy^arbonyl-Ci-Cs-alkyl having in each case 1 to 13 fluorine, chlorine and/or bromine atoms;
(Ci-Cg-alkyl)carbonyl, (C]-C8-alkoxy)carbonyl, (Ci-C4-alkoxy-C)-C4-alkyl)carbonylJ (C3-C8-cycloalkyl)carbonyl; (Ci-C6-haloalkyl)carbonyl, (Ci-C6-haloalkoxy)carbonyl, (halo-C]-C4-alkoxy-CrC4-alkyl)carbonyl, (C3-C8-halocycloalkyI)carbonyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; or -C(=O)C(=O)R3, -CONR^R7 or -CH2NR8R9,
R5 represents hydrogen, Ci-Cg-alkyl, CrC8-alkoxy, CrC4-aIkoxy-Ci-C4-alkyl, C3-C8-cycloalkyl; CrC6-haloalkyl, C]-C6-haIoalkoxy, halo-CrC4-aIkoxy-C|-C4-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R6 and R7 independently of one another each represent hydrogen, Ci-Cg-alkyl, Ci-C4-alkoxy-CrC4-alkyl, C3-C8-cycloalkyl; CrC8-haloalkyl, halo-C]-C4-alkoxy-CrC4-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R6 and R7 furthermore together with the nitrogen atom to which they are attached form a saturated heterocycle having 5 to 8 ring atoms which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and Ci-C4-alkyl, where the heterocycle may contain 1 or 2 further nonadjacent heteroatoms from the group consisting of oxygen, sulphur and NR10,
R8 and R9 independently of one another, represent hydrogen, C|-C8-alkyl, C3-Cs-cycloalkyl; C)-C8-haloalkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R8 and R9 furthermore together with the nitrogen atom to which they are attached form a saturated heterocycle having 5 to 8 ring atoms which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and Ci-C4-alkyl, where the heterocycle may contain 1 or 2 further nonadjacent heteroatoms from the group consisting of oxygen, sulphur and NR10,
R10 represents hydrogen or Ci-C6-alkyl,
A represents the radical of the formula (A 1)
(Figure Removed) (A 1) in which
R11 represents hydrogen, halogen, hydroxyl, cyano, d-C6-alkyI, CrC4-haloalkyl, Ci-C4-haloalkoxy or C]-C4-haloalkylthio having in each case 1 to 5 halogen atoms,
or
A represents the radical of the formula (A2)
K
"
N (A2) in which
CH3
R12 represents chlorine, iodine or dichloromethyl,
or
A represents the radical of the formula (A3)
(Figure Removed) R13 represents CrC4-alkyl or Ci-C4-haloalkyl having 1 to 5 halogen atoms, or A represents the radical of the formula (A4)

(Figure Removed) R13 represents CrC4-alkyl or GrC4-haloalkyl having 1 to 5 halogen atoms, or A represents the radical of the formula (A5)

(Figure Removed)RH represents CrC4-alkyl or CrC4-haloaIkyl having 1 to 5 halogen atoms, or A represents the radical of the formula (A6)



R15 represents hydrogen, halogen, CrC4-alkyl or d-C4-haloalkyl having 1 to 5 halogen
atoms, or A represents the radical of the formula (A7)
(Figure Removed) R16 represents halogen, hydroxyl, Ci-C4-alkyl, CrC4-alkoxy, Ci-Calkylthio, C]-C4-haloalkyl, CrC4-haloalkylthio or CrC4-haloalkoxy having in each case 1 to 5 halogen atoms,
or(Figure Removed)
A represents the radical of the formula (A8)
represents the radical of the formula (A9)
(Figure Removed)or
A represents the radical of the formula (A 10)
(Figure Removed) X represents O (oxygen) or S (sulphur), or A represents the radical of the formula (All)
(Figure Removed) X represents O (oxygen) or S (sulphur), R18 represents iodine or methyl.
The compounds according to the invention can, if appropriate, be present as mixtures of various possible isomeric forms, in particular of stereoisomers, such as, for example, E and Z, threo and erythro, and also optical isomers, and, if appropriate, also of tautomers. What is claimed are both the two E and the Z isomers, and also the threo and erythro and the optical isomers, any mixtures of these isomers and the possible tautomeric forms.
Furthermore, it has been found that silylated carboxamides of the formula (I) are obtained when a) carboxylic acid derivatives of the formula (H) O
in which
X1 represents halogen or hydroxyl and
A is as defined above
are reacted with amines of the formula (HI)
(Figure Removed) in which R, L, R1, R2, R3 and R4 are as defined above,
if appropriate in the presence of a catalyst, if appropriate in the presence of a condensing
agent, if appropriate in the presence of an acid binder and if appropriate in the presence of a
diluent, or b) silylated carboxamides of the formula (I-1)

(Figure Removed) in which R, L, R1, R2, R3 and A are as defined above, are reacted with halides of the formula (VET)
D4a V2
R ~~x (vm)
in which
X2 represents chlorine, bromine or iodine,
R4a represents Ci-Cg-alkyl, Q-Ce-alkylsulphinyl, Ci-C6-alkylsulphonyl, CrC4-alkoxy-C]-C4-alkyl, Cj-Cg-cycloalkyl; CrC6-haloalkyl, C]-C4-haloalkylthio, CrC4-haloalkylsulphinyl, C]-C4-haloalkylsulphonyl, halo-Ci-C4-alkoxy-CrC4-alkyl, C3-Cg-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; formyl, formyl-Ci-C3-alkyl, (C]-C3-alkyl)carbonyl-C]-C3-alkyl, (CrC3-alkoxy)carbonyl-CrC3-alkyl; halo-(Ci-C3-alkyl)carbonyl-Ci-C3-alkyl, halo-(Cj-C3-alkoxy)carbonyl-Ci-C3-alkyl having in each case 1 to 13 fluorine, chlorine and/or bromine atoms;
(Ci-C8-alkyl)carbonyl, (Ci-Cs-alkoxy)carbonyl, (C]-C4-alkoxy-C|-C4-alkyl)carbonyl, (Cs-Cg-cycloalkyOcarbonyl; (Ci-C6-haloalkyl)carbonyIs (Ci-C6-haloalkoxy)carbonyl, (halo-C]-C4-alkoxy-Ci-C4-alkyl)carbonyl, (C3-Cg-halocycloalkyl)carbonyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; or -C(=O)C(=O)RS, -CONRV or -CH2NR8R9, where R5, R6, R7, R8 and R9 are as defined in Claim 1,
in the presence of a base and in the presence of a diluent.
Finally, it has been found that the novel silylated carboxamides of the formula (I) have very good microbicidal properties and can be used for controlling unwanted microorganisms both in crop protection and in the protection of materials.
The formula (I) provides a general definition of the silylated carboxamides according to the invention. Preferred radical definitions of the formulae shown above and below are given below. These definitions apply both to the end products of the formula (I) and likewise to all intermediates.
R preferably represents hydrogen.
R furthermore preferably represents fluorine, where fluorine is particularly preferably located
in the 4-, 5- or 6-position, very particularly preferably in the 4- or 6-position, especially in the
4-position, of the anilide radical [cf. formula (I) above]. R furthermore preferably represents chlorine, where chlorine is particularly preferably located
in the 5-position of the anilide radical [cf. formula (I) above]. R furthermore preferably represents methyl, where methyl is particularly preferably located in
the 3-position of the anilide radical [cf. formula (I) above]. R furthermore preferably represents trifluoromethyl, where trifluoromethyl is particularly
preferably located in the 4- or 5-position of the anilide radical [cf. formula (I) above].
L preferably represents a direct bond or represents optionally halogen-substituted straight-chain
or branched Cj-Ce-alkylene, C2-C6-alkenylene or C2-C6-alkynylene. L particularly preferably represents a direct bond or represents -CH2-, -(CH^-, "(CH2)3-,
-CH(Me)-, -CH(Me)CH2-, -CH2CH(Me)-, -CH(Me)CH(Me>, -C(Me2)CH2-)
-CH(Me)-(CH2)2-, -CH(Me)-(CH2)3-, -CH=CH-, -C(Me)=CH- or -OCX
L very particularly preferably represents -(CR^-, -(CH2)3-, -CH(Me)-, -CH(Me)CH2-,
-CH(MeXCH2)2-, -CH(MeMCH2)3-, -CH=CH-, -C(Me)=CH- or -OC-.
R1 and R2 independently of one another preferably represent CVCe-alkyl, CpCe-alkoxy, Ci-C3-
alkoxy-Ci-C3-alkyl or CrC3-alkylthio-C,-C3-alkyl. R1 and R2 independently of one another, particularly preferably represent methyl, ethyl, methoxy,
ethoxy, methoxymethyl, ethoxymethyl, methoxyethyl, ethoxyethyl, methylthiomethyl,
ethylthiomethyl, methylthioethyl or ethylthioethyl. R1 and R2 independently of one another, very particularly preferably represent methyl, methoxy,
methoxymethyl or methylthiomethyl. R1 and R2 especially preferably each represent methyl.
R3 preferably represents Ci-Q-alkyl, Ci-C6-alkoxy, Ci-C3-alkoxy-CrC3-alkyl, Ci-C3-alkylthio-
Ci-C3-alkyl, C3-C6-cycloalkyl, phenyl or benzyl. R3 particularly preferably represents methyl, ethyl, n- or isopropyl, n-, sec-, iso- or tert-butyl,
methoxy, ethoxy, n- or isopropoxy, n-, sec-, iso- or tert-butoxy, methoxymethyl, ethoxy-
methyl, methoxyethyl, ethoxyethyl, methylthiomethyl, ethylthiomethyl, methylthioethyl,
ethylthioethyl, cyclopropyl, phenyl or benzyl. R3 very particularly preferably represents methyl, ethyl, n- or isopropyl, iso- or tert-butyl,
methoxy, isopropoxy, iso- or tert-butoxy, methoxymethyl, methylthiomethyl or phenyl. R3 especially preferably represents methyl, ethyl, n- or isopropyl, iso- or tert-butyl, methoxy,
isopropoxy, iso- or tert-butoxy. R3 most preferably represents methyl.
R4 preferably represents hydrogen, CpCe-alkyl, C)-C4-alkylsulphinyl, CrC4-alkylsulphonyl, C\-C3-alkoxy-C,-Cralkyl, C3-C6-cycloalkyl; CrC4-haloalkyl, d-C4-haloalkylthio, C,-C4-haloalkylsulphinyl, C]-C4-haloalkylsulphonyl, halo-Ci-C3-alkoxy-Ci-C3-alkyl, C3-Cg-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; formyl, formyl-Ci-C3-alkyl, (C,-C3-alkyl)carbonyl-Ci-C3-alkyl, (Ci-C3-alkoxy)carbonyI-CrC3-alkyl; halo-(CrC3-alkyl)carbonyl-C]-C3-alkyl, halo-(Ci-C3-alkoxy)carbonyl-C]-C3-alkyl having in each case 1 to 13 fluorine, chlorine and/or bromine atoms;
(CrC6-alkyl)carbonyl, (CrC4-alkoxy)carbonyl, (Ci-C3-alkoxy-Ci-C3-alkyl)carbonyl, (C3-C6-cycloalkyl)carbonyl; (G]-C4-haloalkyl)carbonyl, (Ci-C4-haloalkoxy)carbonyl, (halo-CrC3-alkoxy-Ci-C3-alkyl)carbonyl, (C3-C6-halocycloalkyl)carbonyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; or -C(=O)C(=O)R5, -CONR6R7 or -CH2NR8R9.
R4 particularly preferably represents hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or
tert-butyl, pentyl or hexyl, methylsulphinyl, ethylsulphinyl, n- or isopropylsulphinyl, n-, iso-,
sec- or tert-butylsulphinyl, methylsulphonyl, ethylsulphonyl, n- or isopropylsulphonyl, n-,
iso-, sec- or tert-butylsulphonyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl,
cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, trichloromethyl, trifluoroethyl,
difluoromethylthio, difluorochloromethylthio, trifluoromethylthio, trifluoromethylsulphinyl,
trifluoromethylsulphonyl, trifluoromethoxymethyl, formyl, -CH2-CHO, -(CH2)rCHO,
-CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2, -(CH2)2-CO-CH3,
-(CH2)2-CO-CH2CH3, -(CH2)2-CO-CH(CH3)2, -CH2-CO2CH3, -CH2-CO2CH2CH3, -CH2-C02CH(CH3)2, -(CH2)rC02CH3, -(CH2)rCO2CH2CH3, -(CH2)2-CO2CH(CH3)2, -CH2-CO-CF3, -CH2-CO-CC13, -CH2-CO-CH2CF3, -CH2-CO-CH2CC13, -(CH2)2-CO-CH2CF3, -(CH2)rCO-CH2CCl3, -CH2-CO2CH2CF3, -CH2-CO2CF2CF3, -CH2-CO2CH2CC13, -CH2-C02CC12CC13, -(CH2)2-C02CH2CF3, -(CH2)2-CO2CF2CF3, -(CH2)2-CO2CH2CCl3,
-(CH2)2-CO2CC12CC13;
methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, tert-butylcarbonyl,
methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, cyclopropylcarbonyl; trifluoro-
methylcarbonyl, trifluoromethoxycarbonyl, or -C(=O)C(==O)R5, -CONRV or -CH2NR8R9.
R4 very particularly preferably represents hydrogen, methyl, methoxymethyl, formyl,
-CH2-CHO, -(CH2)2-CHO, -CH2-CO-CH3, -CHrCO-CH2CH3, -CHrCO-CHCCHsX
-C(=O)CHO, -C(=O)C(=O)CH3, -C(=O)C(=O)CH2OCH3, -C(=O)CO2CH3,
-C(=0)C02CH2CH3.
R4 especially preferably represents hydrogen.
R5 preferably represents hydrogen, Cj-Cs-alkyl, Cj-Cralkoxy, C]-C3-alkoxy-Ci-C3-alkyl, C3-Ce-cycloalkyl; C)-C4-haloalkyl, CrC4-haloalkoxy, halo-Ci-Cs-alkoxy-Cj-Cralkyl, C3-C6-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms.
R5 particularly preferably represents hydrogen, methyl, ethyl, n- or isopropyl, tert-butyl, methoxy, ethoxy, n- or isopropoxy, tert-butoxy, methoxymethyl, cyclopropyl; trifluoro-methyl, trifluoromethoxy.
R6 and R7 independently of one another preferably represent hydrogen. CrC6-alkyl, C|-C3-alkoxy-Cj-C3-alkyl, C3-C6-cycloalkyl; CrC4-haloalkyl, halo-Ci-C3-alkoxy-CrC3-alkyl, C3-C6-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms.
R6 and R7 furthermore together with the nitrogen atom to which they are attached preferably form a saturated heterocycle having 5 or 6 ring atoms which is optionally mono- to tetrasubstituted by identical or different substituents from the group consisting of halogen and C]-C4-alkyl, where the heterocycle may contain 1 or 2 further non-adjacent heteroatoms from the group consisting of oxygen, sulphur and NR10.
R6 and R7 independently of one another, particularly preferably represent hydrogen, methyl, ethyl, n-or isopropyl, n-, iso-, sec- or tert-butyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl; trifluoromethyl, trichloromethyl, trifluoroethyl, trifluoromethoxymethyl.
R6 and R7 furthermore together with the nitrogen atom to which they are attached particularly preferably form a saturated heterocycle from the group consisting of morpholine, thiomorpholine and piperazine, which heterocycle is optionally mono- to tetrasubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine and methyl, where the piperazine may be substituted on the second nitrogen atom by R10.

R8 aund R9 independently of one another, preferably represent hydrogen, C]-C6-alkylj C3-C6-cyclo-alkyl; Ci-C4-haloalkyl, C3-C6-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms.
R8 and R9 furthermore together with the nitrogen atom to which they are attached preferably form a saturated heterocycle having 5 or 6 ring atoms which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and Ci-C4-alkyl, where the heterocycle may contain 1 or 2 further non-adjacent heteroatoms from the group consisting of oxygen, sulphur and NR10.
R8 and R9 independently of one another, particularly preferably represent hydrogen, methyl, ethyl, n-or isopropyl, n-, iso-, sec- or tert-butyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl; trifluoromethyl, trichloromethyl, trifluoroethyl, trifluoromethoxymethyl.
R8 and R9 furthermore together with the nitrogen atom to which they are attached particularly preferably form a saturated heterocycle from the group consisting of morpholine, thiomorpholine and piperazine, which heterocycle is optionally mono- to tetrasubstituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine and methyl, where the piperazine may be substituted on the second nitrogen atom by R10.
R10 preferably represents hydrogen or C]-C4-alkyl.
R10 particularly preferably represents hydrogen, methyl, ethyl, n- or isopropyl, n-, iso-, sec- or tert-butyl.
A preferably represents one of the radicals A1, A2, A5 or A7 shown above.
A furthermore preferably represents A6, A10 or A11.
A particularly preferably represents the radical Al.
A furthermore particularly preferably represents the radical A2.
A furthermore particularly preferably represents the radical A5.
A furthermore particularly preferably represents the radical A6.
A furthermore particularly preferably represents the radical A7.
A furthermore particularly preferably represents the radical A10.
A furthermore particularly preferably represents the radical All.
R11 preferably represents hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, Ci-C4-alkyl, Cj-Ca-haloalkyl, Ci-C2-haloalkoxy or Ci-C2-haloalkylthio having in each case 1 to 5 fluorine, chlorine and/or bromine atoms.
R11 particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, trifluoromethylthio, difluoromethylthio, difluorochloromethylthio or trichloromethylthio.
R11 very particularly preferably represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, difluoromethyl, trifluoromethyl or trichloromethyl.
R" especially preferably represents chlorine, bromine, iodine, methyl, difluoromethyl or trifluoromethyl.
R12 preferably represents iodine.
R12 furthermore preferably represents chlorine.
R12 furthermore preferably represents dichloromethyl.
R13 preferably represents methyl, ethyl or CrC2-haIoalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
R13 particularly preferably represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R13 very particularly preferably represents methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R14 preferably represents methyl, ethyl or Cj-Ca-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
R14 particularly preferably represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
R14 very particularly preferably represents methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R14 especially preferably represents methyl or trifluoromethyl.
R15 preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or Ci-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
R15 particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl.
R16 preferably represents fluorine, chlorine, bromine, iodine, hydroxyl, CrC4-alkyl, methoxy, ethoxy, methylthio, ethylthio, difluoromethylthio, trifluoromethylthio, C]-C2-haloalkyl or Q-C2-haloalkoxy having in each case 1 to 5 fluorine, chlorine and/or bromine atoms.
R16 particularly preferably represents fluorine, chlorine, bromine, iodine, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, trichloromethyl.
R16 very particularly preferably represents fluorine, chlorine, bromine, iodine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
R17 preferably represents methyl, ethyl, n-propyl or isopropyl. R17 particularly preferably represents methyl or ethyl.
X preferably represents O (oxygen).
X furthermore preferably represents S (sulphur).
R18 preferably represents iodine.
R18 furthermore preferably represents methyl.
Emphasis is furthermore given to compounds of the formula (1-1)
(Figure Removed) R2, R3 and A are as defined above.
Emphasis is furthermore given to compounds of the formula (1-2)
(Figure Removed) in which R, L, R1, R% R , R a and A are as defined above.
R4a preferably represents Ci-Ce-alkyl, Ci-C4-alkylsulphinyl, Ci-C4-alkylsulphonyl, CrC3-alkoxy-CrC3-alkyl, C3-C6-cycloalkyl; C,-C4-haloalkyl, Ci-C4-haloalkylthio, CrC4-haloalkyl-sulphinyl, CrC4-haloalkylsulphonyl, halo-Ci-C3-alkoxy-Ci-C3-alkyl, C3-C8-halocycloalkyl
having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; formyl, formyl-C]-C3-alkyl, (CrC3-alkyl)carbonyl-C,-C3-alkyl, (C,-C3-alkoxy)carbonyl-C,-C3-alkyl; halo-(C,-C3-alkyl)carbonyl-C]-C3-alkyl, halo-(Ci-C3-alkoxy)carbonyl-Ci-C3-alkyl having in each case 1 to 13 fluorine, chlorine and/or bromine atoms;
(Ci-C6-alkyl)carbonyl, (d-C4-alkoxy)carbonyl, (C]-C3-alkoxy-CrC3-alkyl)carbonyl, (C3-C6-cycloalkyl)carbonyl; (Ci-C4-haloalkyl)carbonyl, (Ci-C4-haloalkoxy)carbonyl, (halo-C]-C3-alkoxy-CrC3-alkyl)carbonyl, (C3-C6-halocycloalkyl)carbonyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; or -C(=O)C(=O)R5, -CONRV or -CH2NR8R9, where R5, R6, R7, R8 and R9 are as defined above.
R4a particularly preferably represents methyl, ethyl, n- or isopropyl, n-, iso-, sec- or tert-butyl,
pentyl or hexyl, methylsulphinyl, ethylsulphinyl, n- or isopropylsulphinyl, n-, iso-, sec- or
tert-butylsulphinyl, methylsulphonyl, ethylsulphonyl, n- or isopropylsulphonyl, n-, iso-, sec-
or tert-butylsulphonyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl,
cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, trichloromethyl, trifluoroethyl,
difluoromethylthio, difluorochloromethylthio, trifluoromethylthio, trifluoromethylsulphinyl,
trifluoromethylsulphonyl, trifluoromethoxymethyl; formyl, -CH2-CHO, -(CH2)2-CHO)
-CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2, -(CH2>rCO-CH3,
-(CH2)2-CO-CH2CH3, -(CH^-CO-CHCCH^, -CH2-CO2CH3, -CH2-CO2CH2CH3, -CH2-C02CH(CH3)2, -(CH2)2-C02CH3, -(CH2)2-CO2CH2CH3, -(CH^-COzCHtCH,),, -CH2-CO-CF3, -CH2-CO-CC13, -CH2-CO-CH2CF3, -CH2-CO-CH2CC13, -(CH2}rCO-CH2CF3, -(CH2)2-CO-CH2CC13, -CH2-CO2CH2CF3, -CH2-CO2CF2CF3, -CH2-CO2CH2CC13, -CH2-C02CC12CC13, -(CH2)2-C02CH2CF3, -(CH2)2-CO2CF2CF3, -(CH2)2-CO2CH2CC13) -(CH2)rC02CCl2CCl^
methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, tert-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, cyclopropylcarbonyl, trifluoro-methylcarbonyl, trifluoromethoxycarbonyl, or -C(=O)C(=O)R5, -CONR'Tl7 or -CH2NR8R9, where R5, R6, R7, R8 and R9 are as defined above.
R4a very particularly preferably represents methyl, methoxymethyl, formyl, -CH2-CHO, -(CH2)rCHO, -CH2-CO-CH3, -CH2-CO-CH2CH3, -CH2-CO-CH(CH3)2> -C(=O)CHO, -C(=O)C(=O)CH3, -C(=O)C(=O)CH2OCH3, -C(=O)CO2CH3, -C(=O)CO2CH2CH3.
(Figure Removed) Emphasis is furthermore given to compounds of the formula (1-3)

in which R, R1, R2, R3, R4 and A are as defined above.
Emphasis is furthermore given to compounds of the formula (1-4)
(Figure Removed) in which R, R1, R2, R3, R4 and A are as defined above.
Saturated or unsaturated hydrocarbon radicals, such as alkyl or alkenyl, can in each case be straight-chain or branched, as far as this is possible, including in combination with heteroatoms, such as, for example, in alkoxy.
Optionally substituted radicals may be mono- or polysubstituted, where in the case of polysubstitution the substituents can be identical or different.
Halogen-substituted radicals, such as, for example, haloalkyl, are mono- or polyhalogenated. In the case of polyhalogenation, the halogen atoms can be identical or different. Here, halogen denotes fluorine, chlorine, bromine and iodine, in particular fluorine, chlorine and bromine.
The general or preferred radical definitions or illustrations given above can be combined between the respective ranges and preferred ranges as desired. The definitions apply both to the end products and, correspondingly, to the precursors and intermediates.
Description of the processes and intermediates Process (a)
Using, for example, 2-chlorobenzoyl chloride and {2-[l-methyl-2-(trimethylsilyl)ethyl]phenyl}amine as starting materials, the course of the process (a) according to the invention can be illustrated by the formula scheme below. (Figure Removed)
The formula (II) provides a general definition of the carboxylic acid derivatives required as starting materials for carrying out the process (a) according to the invention. In this formula (IT), A preferably, particularly preferably and very particularly preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred and very particularly preferred, respectively, for these radicals. X1 preferably referes to chlorine, bromine or hydroxyl.
Carboxylic acid derivatives of the formula (II) are known and/or can be obtained by known methods (cf. WO 93/11117, EP-A 0 545 099, EP-A 0 589 301, EP-A 0 589 313 and DE-A 103 25 439.0).
The formula (ID) provides a general definition of the amines furthermore required as starting materials for carrying out the process (a) according to the invention. In this formula (III), R, L, R1, R2, R3 and R4 preferably, particularly preferably and very particularly preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred and very particularly preferred, respectively, for these radicals.
The amines of the formula (HI) are known and/or can be obtained in a known manner (cf. WO 03/080628 and the Preparation Examples).
Amines of the formula (ffl) in which R4 does not represent hydrogen can be obtained, for example, by reacting amines of the formula (Hl-a)(Figure Removed) in which R, L, R1, R2 and R3 are as defined above with halides of the formula (VHI)
D4a V2
R —X (vuj)
in which X2 and R4a are as defined above [the reaction conditions of the process (b) according to the invention apply correspondingly].
Process (b)
(Figure Removed) Using 2-chloro-N-{2-[l-methyI-2-(trimethylsilyl)ethyl]phenyl}benzamide and acetyl chloride as starting materials, the course of the process (b) according to the invention can be illustrated by the following formula scheme:


The formula (1-1) provides a general definition of the silylated carboxamides required as starting materials for carrying out the process (b) according to the invention. In this formula (1-1), R, L, R1, R2, R3, R4 and A preferably, particularly preferably and very particularly preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred and very particularly preferred, respectively, for these radicals.
The compounds of the formula (1-1) are compounds according to the invention and can be prepared by process (a).
Reaction conditions
Suitable diluents for carrying out the process (a) according to the invention are all inert organic solvents. These preferably include aliphatic, alicyclic or aromatic hydrocarbons, such as, for example, petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, such as, for example, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane; ethers, such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; nitriles, such as acetonitrile, propionitrile, n- or i-butyronitrile or benzonitrile; amides, such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide; mixtures thereof with water or pure water.
Suitable diluents for carrying out the process (b) according to the invention are all inert organic solvents. These preferably include aliphatic, alicyclic or aromatic hydrocarbons, such as, for example, petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, such as, for example, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane; ethers, such as
diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; amides, such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide. The process (a) according to the invention is, if appropriate, carried out in the presence of a suitable acid acceptor. Suitable acid acceptors are all customary inorganic or organic bases. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates, such as, for example, sodium hydride, sodium amide, lithium diisopropylamide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium acetate, potassium acetate, calcium acetate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or ammonium carbonate, and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N,N-dimethylamino-pyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU).
The process (b) according to the invention is carried out in the presence of a suitable base. Suitable bases are all customary inorganic or organic bases. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates, bicarbonates, such as, for example, sodium hydride, sodium amide, lithium diisopropylamide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium hydroxide, potassium hydroxide, ammonium hydroxide, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or cesium carbonate; and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU).
The process (a) according to the invention is, if appropriate, carried out in the presence of a suitable condensing agent. Suitable condensing agents are all condensing agents which are customarily used for such amidation reactions. Acid halide formers, such as phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride or thionyl chloride; anhydride formers, such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulphonyl chloride; carbodiimides, such as N,N'-dicyclohexyl-carbodiimide (DCC), or other customary condensing agents, such as phosphorus pentoxide, poh/phosphoric acid, N,N'-carbonyldiimidazole, 2-ethoxy-N-ethoxycarbonyl-l,2-dihydroquinoline (EEDQ), triphenylphosphine/carbon tetrachloride or bromotripyrrolidinophosphonium hexafluorophosphate may be mentioned by way of example.
The process (a) according to the invention is, if appropriate, carried out in the presence of a catalyst. Examples which may be mentioned are 4-dimethylaminopyridine, 1-hydroxybenzotriazole or dimethylformamide.
When carrying out the process (a) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the process is carried out at temperatures of from 0°C to 150°C, preferably at temperatures from 0°C to 120°C, particularly preferably at temperatures from 10°Cto80°C.
When carrying out the process (b) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general the process is carried out at temperatures of from 0°C to 150°C, preferably at temperatures of from 20°C to 110°C.
For carrying out the process (a) according to the invention for preparing the compounds of the formula (I), in general from 0.8 to 15 mol, preferably from 0.8 to 8 mol, of amine of the formula (ffl) and from 1 to 3 mol of an acid binder are employed per mole of the carboxylic acid derivative of the formula (H).
For carrying out the process (b) according to the invention, in general from 0.2 to 5 mol, preferably from 0.5 to 2 mol, of a halide of the formula (a) are employed per mole of silylated carboxamide of the formula (I-1).
Unless indicated otherwise, all processes according to the invention are generally carried out under atmospheric pressure. However, it is also possible to operate under elevated or reduced pressure - in general between 0.1 bar and 10 bar.
The compounds according to the invention have potent microbicidal activity and can be employed for controlling unwanted microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials.
Fungicides can be employed in crop protection for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
Bactericides can be employed in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
Some pathogens causing fungal and bacterial diseases which come under the generic names listed
above may be mentioned as examples, but not by way of limitation:
Xanthomonas species, such as, for example, Xanthomonas campestris pv. oryzae;
Pseudomonas species, such as, for example, Pseudomonas syringae pv. lachrymans;
Envinia species, such as, for example, Erwinia amylovora;
Pythium species, such as, for example, Pythium ultimum;
Phytophthora species, such as, for example, Phytophthora infestans;
Pseudoperonospora species, such as, for example, Pseudoperonospora humuli or Pseudoperonospora
cubensis;
Plasmopara species, such as, for example, Plasmopara viticola;
Bremia species, such as, for example, Bremia lactucae;
Peronospora species, such as, for example, Peronospora pisi or P. brassicae;
Erysiphe species, such as, for example, Erysiphe graminis;
Sphaerotheca species, such as, for example, Sphaerotheca fuliginea;
Podosphaera species, such as, for example, Podosphaera leucotricha;
Venturia species, such as, for example, Venturia inaequalis;
Pyrenophora species, such as, for example, Pyrenophora teres or P. graminea
(conidia form: Drechslera, syn: Helminthosporium);
Cochliobolus species, such as, for example, Cochliobolus sativus
(conidia form: Drechslera, syn: Helminthosporium);
Uromyces species, such as, for example, Uromyces appendiculatus;
Puccinia species, such as, for example, Puccinia recondita;
Sclerotinia species, such as, for example, Sclerotinia sclerotiorum;
Tilletia species, such as, for example, Tilletia caries;
Ustilago species, such as, for example, Ustilago nuda or Ustilago avenae;
Pellicularia species, such as, for example, Pellicularia sasakii;
Pyricularia species, such as, for example, Pyricularia oryzae;
Fusarium species, such as, for example, Fusarium culmorum;
Botrytis species, such as, for example, Botrytis cinerea;
Septoria species, such as, for example, Septoria nodorum;
Leptosphaeria species, such as, for example, Leptosphaeria nodorum;
Cercospora species, such as, for example, Cercospora canescens;
Alternaria species, such as, for example, Alternaria brassicae; and
Pseudocercosporella species, such as, for example, Pseudocercosporella herpotrichoides. Rhizoctonia species, such as, for example, Rhizoctonia solani.
The active compounds according to the invention also show a strong invigorating action in plants. Accordingly, they are suitable for mobilizing the internal defences of the plant against attack by unwanted microorganisms.
In the present context, plant-invigorating (resistance-inducing) compounds are to be understood as meaning substances which are capable of stimulating the defence system of plants such that, when the treated plants are subsequently inoculated with unwanted microorganisms, they display substantial resistance to these microorganisms.
In the present case, unwanted microorganisms are to be understood as meaning phytopathogenic fungi, bacteria and viruses. The compounds according to the invention can thus be used to protect plants within a certain period of time after treatment against attack by the pathogens mentioned. The period of time for which this protection is achieved generally extends for 1 to 10 days, preferably 1 to 7 days, from the treatment of the plants with the active compounds.
The fact that the active compounds are well tolerated by plants at the concentrations required for controlling plant diseases permits the treatment of above-ground parts of plants, of propagation stock and seeds, and of the soil.
The active compounds according to the invention can be employed with particularly good results for controlling cereal diseases, such as, for example, against Puccinia species, and of diseases in viticulture and in the cultivation of fruit and vegetables, such as, for example, against Botrytis, Venturia or Alternaria species.
The active compounds according to the invention are also suitable for increasing the yield of crops. In addition, they show reduced toxicity and are well tolerated by plants.
If appropriate, the active compounds according to the invention can, at certain concentrations and application rates, also be employed as herbicides, for regulating plant growth and for controlling animal pests. If appropriate, they can also be used as intermediates or precursors in the synthesis of other active compounds.
According to the invention, it is possible to treat all plants and parts of plants. Plants are to be understood here as meaning all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including plant cultivars which can or cannot be protected by plant breeders' certificates. Parts of plants are to be understood as meaning all above-ground and below-ground parts and organs of plants, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stems, trunks, flowers, fruit-bodies, fruits and seeds and also roots, tubers and rhizomes. Parts of plants also include harvested material and vegetative and generative propagation material, for example seedlings, tubers, rhizomes, cuttings and seeds.
The treatment of the plants and parts of plants according to the invention with the active compounds is carried out directly or by action on their environment, habitat or storage area according to customary treatment methods, for example by dipping, spraying, evaporating, atomizing, broadcasting, brushing-on and, in the case of propagation material, in particular in the case of seeds, furthermore by one- or multilayer coating.
In the protection of materials, the compounds according to the invention can be employed for protecting industrial materials against infection with, and destruction by, unwanted microorganisms.
Industrial materials in the present context are understood as meaning non-living materials which have been prepared for use in industry. For example, industrial materials which are intended to be protected by active compounds according to the invention from microbial change or destruction can be tackifiers, sizes, paper and board, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be infected with, or destroyed by, microorganisms. Parts of production plants, for example cooling-water circuits, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected. Industrial materials which may be mentioned within the scope of the present invention are preferably tackifiers, sizes, paper and board, leather, wood, paints, cooling lubricants and heat-transfer liquids, particularly preferably wood.
Microorganisms capable of degrading or changing the industrial materials which may be mentioned are, for example, bacteria, fungi, yeasts, algae and slime organisms. The active compounds according to the invention preferably act against fungi, in particular moulds, wood-discolouring and wood-destroying fungi (Basidiomycetes) and against slime organisms and algae. Microorganisms of the following genera may be mentioned as examples:
Alternaria, such as Alternaria tenuis,
Aspergillus, such as Aspergillus niger,
Chaetomium, such as Chaetomium globosum,
Coniophora, such as Coniophora puetana,
Lentinus, such as Lentinus tigrinus,
Penicillium, such as Penicillium glaucum,
Polyporus, such as Polyporus versicolor,
Aureobasidium, such as Aureobasidium pullulans,
Sclerophoma, such as Sclerophoma pityophila,
Trichoderma, such as Trichoderma viride,
Escherichia, such as Escherichia coli,
Pseudomonas, such as Pseudomonas aeruginosa, and
Staphylococcus, such as Staphylococcus aureus.
Depending on their particular physical and/or chemical properties, the active compounds can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations.
These formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is liquid solvents, liquefied gases under pressure, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam formers. If the extender used is water, it is also possible to employ, for example, organic solvents as auxiliary solvents. Essentially, suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide or dimethyl sulphoxide, or else water. Liquefied gaseous extenders or carriers are to be understood as meaning liquids which are gaseous at standard temperature and under atmospheric pressure, for example aerosol propellants such as halogenated hydrocarbons, or else butane, propane, nitrogen and carbon dioxide. Suitable solid carriers are: for example ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals such as finely divided silica, alumina and silicates. Suitable solid
carriers for granules are: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, or else synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks. Suitable emulsifiers and/or foam formers are: for example nonionic and anionic emulsifiers, such as polyoxy-ethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates, or else protein hydrolysates. Suitable dispersants are: for example lignosulphite waste liquors and methylcellulose.
Tackifiers such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids can be used in the formulations. Other possible additives are mineral and vegetable oils.
It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
The formulations generally comprise between 0.1 and 95 per cent by weight of active compound, preferably between 0.5 and 90%.
The active compounds according to the invention can, as such or in their formulations, also be used in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, to broaden, for example, the activity spectrum or to prevent development of resistance. In many cases, synergistic effects are obtained, i.e. the activity of the mixture is greater than the activity of the individual components.
Suitable mixing components are, for example, the following compounds: Fungicides:
2-phenylphenol; 8-hydroxyquinoline sulphate; acibenzolar-S-methyl; aldimorph; amidoflumet; ampropylfos; ampropylfos-potassium; andoprim; anilazine; azaconazole; azoxystrobin; benalaxyl; benodanil; benomyl; benthiavalicarb-isopropyl; benzamacril; benzamacril-isobutyl; bilanafos; binapacryl; biphenyl; bitertanol; blasticidin-S; bromuconazole; bupirimate; buthiobate; butylamine; calcium polysulphide; capsimycin; captafol; captan; carbendazim; carboxin; carpropamid; carvone; chinomethionat; chlobenthiazone; chlorfenazole; chloroneb; chlorothalonil; chlozolinate; clozylacon; cyazofamid; cyflufenamid; cymoxanil; cyproconazole; cyprodinil; cyprofuram; Dagger G; debacarb;
dichlofluanid; dichlone; dichlorophen; diclocymet; diclomezine; dicloran; diethofencarb;
difenoconazole; diflumetorim; dimethirimol; dimethomorph; dimoxystrobin; diniconazole;
diniconazole-M; dinocap; diphenylamine; dipyrithione; ditalimfos; dithianon; dodine; drazoxolon;
edifenphos; epoxiconazole; ethaboxam; ethirimol; etridiazole; famoxadone; fenamidone; fenapanil;
fenarimol; fenbuconazole; fenfiiram; fenhexamid; fenitropan; fenoxanil; fenpiclonil; fenpropidin;
fenpropimorph; ferbam; fluazinam; flubenzimine; fludioxonil; flumetover; flumorph; fluoromide;
fluoxastrobin; fluquinconazole; flurprimidol; flusilazole; flusulphamide; flutolanil; flutriafol; folpet;
fosetyl-Al; fosetyl-sodium; fiiberidazole; furalaxyl; furametpyr; furcarbanil; furmecyclox; guazatine;
hexachlorobenzene; hexaconazole; hymexazole; imazalil; imibenconazole; iminoctadine triacetate;
iminoctadine tris(albesil); iodocarb; ipconazole; iprobenfos; iprodione; iprovalicarb; irumamycin;
isoprothiolane; isovaledione; kasugamycin; kresoxim-methyl; mancozeb; maneb; meferimzone;
mepanipyrim; mepronil; metalaxyl; metalaxyl-M; metconazole; methasulphocarb; methfuroxam;
metiram; metominostrobin; metsulphovax; mildiomycin; myclobutanil; myclozolin; natamycin;
nicobifen; nitrothal-isopropyl; noviflumuron; nuarimol; ofurace; orysastrobin; oxadixyl; oxolinic
acid; oxpoconazole; oxycarboxin; oxyfenthiin; paclobutrazole; pefiirazoate; penconazole;
pencycuron; phosdiphen; phthalide; picoxystrobin; piperalin; polyoxins; polyoxorim; probenazole;
prochloraz; procymidone; propamocarb; propanosine-sodium; propiconazole; propineb; proquinazid;
prothioconazole; pyraclostrobin; pyrazophos; pyrifenox; pyrimethanil; pyroquilon; pyroxyfur;
pyrrolenitrine; quinconazole; quinoxyfen; quintozene; simeconazole; spiroxamine; sulphur;
tebuconazole; tecloftalam; tecnazene; tetcyclacis; tetraconazole; thiabendazole; thicyofen;
thifluzamide; thiophanate-methyl; thiram; tioxymid; tolclofos-methyl; tolylfluanid; triadimefon;
triadimenol; triazbutil; triazoxide; tricyclamide; tricyclazole; tridemorph; trifloxystrobin; triflumizole;
triforine; triticonazole; uniconazole; validamycin A; vinclozolin; zineb; ziram; zoxamide; (2S)-N-[2-
[4-[[3-(4-chlorophenyl)-2-propynyl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-
[(methylsulphonyl)amino]butanamide; l-(l-naphthalenyl)-lH-pyrrole-2,5-dione; 2,3,5,6-tetrachloro-
4-(methylsulphonyl)pyridine; 2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide; 2-chloro-N-(2,3-
dihydro-1,1,3-trimethyl-1 H-inden-4-yl)-3-pyridinecarboxamide; 3,4,5-trichloro-2,6-pyridinedicarbo-
nitrile; actinovate; cis-l-(4-chlorophenyl)-2-(lH-l,2,4-triazol-l-yl)cycloheptanol; methyl l-(2,3-
dihydro-2,2-dimethyl-lH-inden-l-yl)-lH-imidazole-5-carboxylate; monopotassium carbonate; N-(6-
methoxy-3-pyridinyl)-cyclopropanecarboxamide; N-butyl-8-( 1,1 -dimethylethyl)-1 -oxa-
spiro[4.5]decane-3-amine; sodium tetrathiocarbonate; and copper salts and preparations, such as Bordeaux mixture; copper hydroxide; copper naphthenate; copper oxychloride; copper sulphate; cufraneb; copper oxide; mancopper; oxine-copper.
Bactericides:
bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
Insecticides / acaricides / nematicides:
abamectin, ABG-9008, acephate, acequinocyl, acetamiprid, acetoprole, acrinathrin, AKD-1022, AKD-3059, AKD-3088, alanycarb, aldicarb, aldoxycarb, allethrin, allethrin IR-isomers, alpha-cyper-methrin (alphamethrin), amidoflumet, aminocarb, amitraz, avermectin, AZ-60541, azadirachtin, aza-methiphos, azinphos-methyl, azinphos-ethyl, azocyclotin, Bacillus popilliae, Bacillus sphaericus, Bacillus subtilis, Bacillus thuringiensis, Bacillus thuringiensis strain EG-2348, Bacillus thuringiensis strain GC-91, Bacillus thuringiensis strain NCTC-11821, baculoviruses, Beauveria bassiana, Beauveria tenella, bendiocarb, benfuracarb, bensultap, benzoxiraate, beta-cyfluthrin, beta-cyper-methrin, bifenazate, bifenthrin, binapacryl, bioallethrin, bioallethrin-S-cyclopentyl-isomer, bioethano methrin, biopermethrin, bioresmethrin, bistrifluron, BPMC, brofenprox, bromophos-ethyl, bromopro-pylate, bromfenvinfos (-methyl), BTG-504, BTG-505, bufencarb, buprofezin, butathiofos, butocarb-oxim, butoxycarboxim, butylpyridaben, cadusafos, camphechlor, carbaryl, carbofuran, carbopheno-thion, carbosulphan, cartap, CGA-50439, chinomethionat, chlordane, chlordimeform, chloethocarb, chlorethoxyfos, chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlormephos, chlorobenzilate, chloro-picrin, chlorproxyfen, chlorpyrifos-methyl, chlorpyrifos (-ethyl), chlovaporthrin, chromafenozide, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocythrin, cloethocarb, clofentezine, clothianidin, clo-thiazoben, codlemone, coumaphos, cyanofenphos, cyanophos, cycloprene, cycloprothrin, Cydia pomonella, cyfluthrin, cyhalothrin, cyhexatin, cypermethrin, cyphenothrin (IR-trans-isomer), cyromazine, DDT, deltamethrin, demeton-S-methyl, demeton-S-methylsulphone, diafenthiuron, diali-fos, diazinon, dichlofenthion, dichlorvos, dicofol, dicrotophos, dicyclanil, diflubenzuron, dimethoate, dimethylvinphos, dinobuton, dinocap, dinotefuran, diofenolan, disulphoton, docusat-sodium, dofena-pyn, DOWCO-439, eflusilanate, emamectin, emamectin-benzoate, empenthrin (IR-isomer), endosulphan, Entomopthora spp., EPN, esfenvalerate, ethiofencarb, ethiprole, ethion, ethoprophos, etofenprox, etoxazole, etrimfos, famphur, fenamiphos, fenazaquin, fenbutatin oxide, fenfluthrin, fenitrothion, fenobucarb, fenothiocarb, fenoxacrim, fenoxycarb, fenpropathrin, fenpyrad, fenpyri-thrin, fenpyroximate, fensulphothion, fenthion, fentrifanil, fenvalerate, fipronil, flonicamid, fluacry-pyrim, fluazuron, flubenzimine, flubrocythrinate, flucycloxuron, flucythrinate, flufenerim, flufenox-uron, flufenprox, flumethrin, flupyrazofos, flutenzin (flufenzine), fluvalinate, fonofos, formetanate, formothion, fosmethilan, fosthiazate, fubfenprox (fluproxyfen), furathiocarb, gamma-HCH, gossyplure, grandlure, granulosis viruses, halfenprox, halofenozide, HCH, HCN-801, heptenophos, hexaflumuron, hexythiazox, hydramethylnone, hydroprene, DCA-2002, imidacloprid,imiprothrin, indoxacarb, iodofenphos, iprobenfos, isazofos, isofenphos, isoprocarb, isoxathion, ivermectin, japonilure, kadethrin, nuclear polyhedrosis viruses, kinoprene, lambda-cyhalothrin, lindane, lufenuron, malathion, mecarbam, mesulphenfos, metaldehyde, metam-sodium, methacrifos, methamidophos, Metharhizium anisopliae, Metharhizium flavoviride, methidathion, methiocarb, methomyl, methoprene, methoxychlor, methoxyfenozide, metolcarb, metoxadiazone, mevinphos, milbemectin, milbemycin, MKI-245, MON-45700, monocrotophos, moxidectin, MTI-800, naled, NC-104, NC-170, NC-184, NC-194, NC-196, niclosamide, nicotine, nitenpyram, nithiazine, NNI-0001, NNI-0101, NNI-0250, NNI-9768, novaluron, noviflumuron, OK-5101, OK-5201, OK-9601, OK-9602, OK-9701, OK-9802, omethoate, oxamyl, oxydemeton-methyl, Paecilomyces fumosoroseus, parathion-methyl, parathion (-ethyl), permethrin (cis-, trans-), petroleum, PH-6045, phenothrin (IR-trans isomer), phenthoate, phorate, phosalone, phosmet, phosphamidon, phosphocarb, phoxim, piperonyl butoxide, pirimicarb, pirimiphos-methyl, pirimiphos-ethyl, prallethrin, profenofos, promecarb, propaphos, propargite, propetamphos, propoxur, prothiofos, prothoate, protrifenbute, py-metrozine, pyraclofos, pyresmethrin, pyrethrum, pyridaben, pyridalyl, pyridaphenthion, pyridathion, pyrimidifen, pyriproxyfen, quinalphos, resmethrin, RH-5849, ribavirin, RU-12457, RU-15525, S-421, S-1833, salithion, sebufos, SI-0009, silafluofen, spinosad, spirodiclofen, spiromesifen, sulphluramid, sulphotep, sulprofos, SZI-121, tau-fluvalinate, tebufenozide, tebufenpyrad, tebupirimfos, teflubenz-uron, tefluthrin, temephos, temivinphos, terbam, terbufos, tetrachlorvinphos, tetradifon, tetramethrin, tetramethrin (IR-isomer), tetrasul, theta-cypennethrin, thiacloprid, thiamethoxam, thiapronil, thiatri-phos, thiocyclam hydrogenoxalate, thiodicarb, thiofanox, thiometon, thiosultap-sodium, thuringiensin, tolfenpyrad, tralocythrin, tralomethrin, transfluthrin, triarathene, triazamate, triazophos, triazuron, trichlophenidine, trichlorfon, triflumuron, trimethacarb, vamidothion, vaniliprole, verbutin, Verticillium lecanii, WL-108477, WL-40027, YI-5201, YI-5301, YI-5302, XMC, xylylcarb, ZA-3274, zeta-cypermethrin, zolaprofos, ZXI-8901, the compound 3-methylphenyl propylcarbamate (tsumacide Z), the compound 3-(5-chloro-3-pyridinyl)-8-(2,2,2-trifluoroethyl)-8-azabicyclo[3.2.1]-octane-3-carbonitrile (CAS-Reg. No. 185982-80-3) and the corresponding 3-endo-isomer (CAS-Reg. No. 185984-60-5) (cf. WO-96/37494, WO-98/25923), and preparations which comprise insecticidally active plant extracts, nematodes, fungi or viruses.
A mixture with other known active compounds, such as herbicides, or with fertilizers and growth regulators, safeners and/or semiochemicals is also possible,
In addition, the compounds of the formula (I) according to the invention also have very good antimycotic activity. They have a very broad antimycotic activity spectrum in particular against dermatophytes and yeasts, moulds and diphasic fungi (for example against Candida species such as Candida albicans, Candida glabrata) and Epidermophyton floccosum, Aspergillus species such as
Aspergillus niger and Aspergillus fumigatus, Trichophyton species such as Trichophyton mentagrophytes, Microsporon species such as Microsporon canis and audouinii. The list of these fungi does by no means limit the mycotic spectrum which can be covered, but is only for illustration.
The active compounds can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. Application is carried out in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming, spreading, etc. It is furthermore possible to apply the active compounds by the ultra-low volume method, or to inject the active compound preparation or the active compound itself into the soil. It is also possible to treat the seeds of the plants.
When using the active compounds according to the invention as fungicides, the application rates can be varied within a relatively wide range, depending on the kind of application. For the treatment of parts of plants, the active compound application rates are generally between 0.1 and 10,000 g/ha, preferably between 10 and 1000 g/ha. For seed dressing, the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 10 g per kilogram of seed. For the treatment of the soil, the active compound application rates are generally between 0.1 and 10,000 g/ha, preferably between 1 and 5,000 g/ha.
As already mentioned above, it is possible to treat all plants and their parts according to the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological breeding, such as crossing or protoplast fusion, and parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof, are treated. The term "parts" or "parts of plants" or "plant parts" has been explained above.
Particularly preferably, plants of the plant cultivars which are in each case commercially available or in use are treated according to the invention. Plant cultivars are to be understood as meaning plants having new properties ("traits") and which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be cultivars, varieties, bio- or genotypes.
Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, diet), the treatment according to the invention may also result in superadditive ("synergistic") effects. Thus, for example, reduced application rates and/or a widening of the activity spectrum and/or an increase in the activity of the substances and compositions which can be used
according to the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, better quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products are possible which exceed the effects which were actually to be expected.
The transgenic plants or plant cultivars (i.e. those obtained by genetic engineering) which are preferably to be treated according to the invention include all plants which, in the genetic modification, received genetic material which imparted particularly advantageous useful properties ("traits") to these plants. Examples of such properties are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, better quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products. Further and particularly emphasized examples of such properties are a better defence of the plants against animal and microbial pests, such as against insects, mites, phytopathogenic fungi, bacteria and/or viruses, and also increased tolerance of the plants to certain herbicidally active compounds. Examples of transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice), maize, soya beans, potatoes, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), and particular emphasis is given to maize, soya beans, potatoes, cotton, tobacco and oilseed rape. Traits that are emphasized are in particular increased defence of the plants against insects, arachnids, nematodes and slugs and snails by toxins formed in the plants, in particular those formed in the plants by the genetic material from Bacillus thuringiensis (for example by the genes CrylA(a), CrylA(b), CrylA(c), CryllA, CryfflA, CryfflB2, Cry9c, Cry2Ab, CrySBb and CrylF and also combinations thereof) (hereinbelow referred to as "Bt plants"). Traits that are also particularly emphasized are the increased defence of the plants against fungi, bacteria and viruses by systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins. Traits that are furthermore particularly emphasized are the increased tolerance of the plants to certain herbicidally active compounds, for example imidazolinones, sulphonylureas, glyphosate or phosphinotricin (for example the "PAT" gene). The genes which impart the desired traits in question can also be present in combination with one another in the transgenic plants. Examples of "Bt plants" which may be mentioned are maize varieties, cotton varieties, soya bean varieties and potato varieties which are sold under the trade names YIELD GARD® (for example maize, cotton, soya beans), KnockOut® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucoton® (cotton) and NewLeaf® (potato). Examples of herbicide-tolerant plants which may be mentioned are maize varieties, cotton varieties and soya bean
varieties which are sold under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soya bean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulphonylureas, for example maize). Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) which may be mentioned also include the varieties sold under the name Clearfield® (for example maize). Of course, these statements also apply to plant cultivars which have these genetic traits or genetic traits still to be developed, and which will be developed and/or marketed in the future.
The plants listed can be treated according to the invention in a particularly advantageous manner with the compounds of the general formula (I) or the active compound mixtures according to the invention. The preferred ranges stated above for the active compounds or mixtures also apply to the treatment of these plants. Particular emphasis is given to the treatment of plants with the compounds or mixtures specifically mentioned in the present text.
The preparation and the use of the active compounds according to the invention is illustrated by the examples below.

(Figure Removed) 425 mg of 2-(2-trimethylsilylethyl)phenylamine (2.2 mmol) and 438 mg (2.0 mmol) of 2-bromo-benzoyl chloride were dissolved in 20 ml of acetonitrile, and 332 mg (2.4 mmol) of potassium carbonate were added. The reaction mixture was stirred at room temperature for 18 h, 20 ml of water were then added, the mixture was extracted with ethyl acetate and the extract was dried over sodium sulphate. Removal of the solvent and column-chromatographic purification on silica gel 60 (mobile phase: methylene chloride) gave 405 mg (54% of theory) of 2-bromo-A/-[2-(2-trimethylsilyl-ethyl)phenyl]benzamide [logP (pH 2.3) = 4.32].
The compounds of the formula (I) listed in table 1 below were also obtained analogously to example 1 and in accordance with the instructions in the general description of preparation processes (a) and (b) according to the invention:
(Figure Removed) 17.7 g of aniline (0.19 mol), 50 g of allyltrimethylsilane (0.44 mol), 1.5 g of aluminium trichloride (0.01 mol) and 0.5 g of aluminium powder (0.02 mol) were mixed and stirred in an autoclave at 255°C for 10 h. After cooling to room temperature, initially 100 ml of toluene and then 40 ml of a 40% strength solution of NaOH in water and 100 ml of water were added, and the mixture was stirred at 35°C for 15 min. After cooling, the mixture was extracted with toluene, the extract was washed with water and dried over potassium carbonate and the solvent was removed under reduced pressure. Distillation (55°C-60°C, 0.08 mbar) gave 1.4g of 2-(l-methyl-2-trimethylsilylethyl)phenylamine [logP (pH 2.3) = 3.05].
(Figure Removed) 4g (20 mmol) of ortho-bromonitrobenzene, 842 mg (1.2mmol) of bis(triphenyl-phosphine)palladium(n) chloride and 230mg (1.2 mmol) of copper(I) iodide were, under argon, initially charged in 40 ml of triethylamine. At room temperature, 2.95 g (30 mmol) of trimethylsilylacetylene were then added dropwise over a period of 10 min, and the mixture was stirred at room temperature for 2 days. The reaction mixture was poured into 50 ml of water and extracted three times with in each case 50 ml of diethyl ether, and the extracts were dried over sodium sulphate and concentrated. Column-chromatographic purification on silica gel 60 (mobile phase: cyclohexane/ethyl acetate 3:1) gave 4.2 g (96% of theory) of trimethyl-(2-nitrophenyl(Figure Removed) ethynyl)silane [logP (pH 2.3) = 4.12].
10.9 g (50 mmol) of trimethyl-(2-nitrophenylethynyl)silane were dissolved in 200ml of methanol, and 0.5 g of palladium-on-carbon (5%) were added. The mixture was then hydrogenated in an autoclave at 4 bar for 12h. Removal of the solvent and column-chromatographic purification on silica gel 60 (mobile phase: methylene chloride) gave 4.1 g of 2-(2-trimethylsilylethyl)phenylamine [logP(pH 2.3) = 2.58].
The given logP values were determined in accordance with EEC Directive 79/831 Annex V.A8 by
HPLC (High Performance Liquid Chromatography) on a reverse-phase column (C 18). Temperature:
43°C.
Mobile phases for the determination in the acidic range (pH 2.3):0.1% aqueous phosphoric acid,
acetonitrile; linear gradient from 10% acetonitrile to 90% acetonitrile.
Calibration was carried out using unbranched alkan-2-ones (3 to 16 carbon atoms) with known logP
values (determination of the logP values by the retention times using linear interpolation between two
successive alkanones).
The lambda-max values were determined in the maxima of the chromatographic signals using the UV
spectra from 200 nm to 400 nm.-34-Use examples
Example A
Venturia test (apple) / protective
Solvent: 24.5 parts by weight of acetone
24.5 parts by weight of dimethylacetamide
Emulsifier: 1 part by weight of alkylaryl polyglycol ether
To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, the plants are inoculated with an aqueous conidia suspension of the apple pathogen Venturia inaequalis and then remain in an incubation cabin at about 20°C and 100% relative atmospheric humidity for one day.
The plants are then placed in a greenhouse at about 21°C and a relative atmospheric humidity of about 90%.
Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
Table A Venturia test (apple) / protective

Active
compound according to the invention Application rate of Efficacy
active compound in g/ha in %
(Figure Removed) Example B
Sphaerotheca test (cucumber) / protective
Solvent: 49 parts by weight of N,N,dimethylformamide
Emulsifler: 1 part by weight of alkylaryl polyglycol ether
To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifler, and the concentrate is diluted with water to the desired concentration.
To test for protective activity, young cucumber plants are sprayed with the preparation of active compound at the stated application rate. One day after the treatment, the plants are inoculated with a spore suspension of Sphaerotheca fuliginea. The plants are then placed in a greenhouse at 70% relative atmospheric humidity and a temperature of 23°C.
Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
(Figure Removed) TableB Sphaerotheca test (cucumber) / protective
Active compound according to the invention Application rate of Efficacy
active compound in g/ha in %
Example C
Puccinia test (wheat) / protective
Solvent: 50 parts by weight of N,N-dimethylacetamide
Emulsifier: 1 part by weight of alkylaryl polyglycol ether
To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, the plants are sprayed with a conidia suspension of Puccinia recondita. The plants remain in an incubation cabin at 20°C and 100% relative atmospheric humidity for 48 hours.
The plants are then placed in a greenhouse at a temperature of about 20°C and a relative atmospheric humidity of 80% to promote the development of rust pustules.
Evaluation is carried out ten days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
compound according to the invention Application rate of Efficacy
active compound in g/ha in %
(Figure Removed)Puccinia test (wheat) / protective



Active
compound according to the invention Application rate of Efficacy
active compound in g/ha in % (Figure Removed)
















WE CLAIM:
1. Silyalated carboxamides of the formula (I)
(Formula Removed)
in which
R represents hydrogen, fluorine, chlorine, methyl, isopropyl, methylthio or trifluoro-
methyl,
L represents a direct bond or represents in each case optionally substituted straight-
chain or branched alkylene (alkanediyl), alkenylene (alkenediyl) or alkynylene (alkyndiyi), R1 and R2 independently of one another represent hydrogen, C1-C8-alkyl, C1-C8-alkoxy, C1-
C4-alkoxy-C1-C4-alkyl, C1-C4-alkylthio-C1-C4-alkyl or C1-C4-haloalkyl, R3 represents hydrogen, C1-C8-alkyl, -C1-C8-alkoxy, C1-C4-alkoxy-C1-C4-alkyl, C1-C4-alkylthio-C1-C4-alkyl, C1-C4-alkenyl, C2-C8-alkynyl, C1-C6-haloalkyl, C2-C6-halo-alkenyl, C2-C6-haloalkynyl, C3-C6-cycloalkyl, or represents in each case optionally substituted phenyl or phenylalkyl, R4 represents hydrogen, C1-C8-alkyl, C1-C6-alkylsulphinyl, C1-C6-alkylsulphonyl, C1-C4-alkoxy-C1-C4-alkyl, C3-C8-cycloalkyl; C1-C6-haloalkyl, C1-C4-haloalkylthio, C1-C4-haloalkylsulphinyl, C1-C4-haloalkylsulphonyl, halo-C1-C4-alkoxy-C1-C4-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; formyl, formyl-C1-C3-ralkyi, (C1-C3-alkyl)carbonyl-C1-C3-alkyl, (C1-C3-alkoxy)carbonyl-C1-C3-alkyl; halo-(C1-C3-alkyl)carbonyl-C1-C3-alkyl, halo-(C1-C3-alkoxy)carbonyl-C1-C3-alkyl having in each case 1 to 13 fluorine, chlorine and/or bromine atoms;
(C1-C8-alkyl)carbonyl, (C1-C8-alkoxy)carbonyl, (C1-C4-alkoxy-C1-C4-alkyl)carbonyl, (C3-C8-cycloalkyl)carbonyl; (C1 -C6-haloalkyl)carbonyl, (C1-C6-haloalkoxy)carbonyl, (halo-C1-C4-alkoxy-C1-C4-alkyl)carbonyl, (C3-C8-halocycloalkyl)carbonyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; or -C(=O)C(=O)R5, -CONR6R7 or-CH2NR8R9, R5 represents hydrogen, C1-C8-alkyl, C1-C8-alkoxy, C1-C4-alkoxy-C1-C4-alkyl, C3-C8-cycloalkyl; C1-C6-haloalkyl, C1-C6-haloalkoxy, halo-C1-C4-alkoxy-C1-C4-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R6 and R7 independently of one another each represent hydrogen, C1-C8-alkyl, C1-C4-alkoxy-C1-C4-alkyi, C3-C8-cycloalkyl; C1-C8-haloalkyl, halo-C1-C4-alkoxy-C1-C4-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R6 and R7 furthermore together with the nitrogen atom to which they are attached form a saturated heterocycle having 5 to 8 ring atoms which is optionally mono- or polysubstituted by identical or different substitnents from the group consisting of halogen and C1-C4-alkyl5 where the heterocycle may contain 1 or 2 further nonadjacent heteroatoms from the group consisting of oxygen, sulphur and NR10,
R8 and R9 independently of one another, represent hydrogen, C1-C8-alkyl, C3-C8-cycloalkyl; C1-C8-haloalkyl, C3-C8-halocycloalkyl having in each case I to 9 fluorine, chlorine and/or bromine atoms,
R8 and R9 furthermore together with the nitrogen atom to which they are attached form a saturated heterocycle having 5 to 8 ring atoms which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and C1-C4-alkyl, where the heterocycle may contain 1 or 2 further nonadjacent heteroatoms from the group consisting of oxygen, sulphur and NR10,
R10 represents hydrogen or C1-C6-alkyl,
A represents the radical of the formula (A2)
(Formula Removed)
(A2) in which
R12 represents chlorine, iodines or dichloromethyl. 2. Stlylated carboxamides of the formula (I) as claimed in claim 1, wherein
R represents hydrogen, fluorine, chlorine, methyl or trifluoromethyl,
L represents a direct bond or represents in each case optionally halogen-substituted
straight-chain or branched C1-C6-alkylene, C2-C6-alkenylene or C2-C6-alkynylene,
R1 and R2 independently of one another represent C1-C6-alkyl, C1-C6-alkoxy, C1-C3-alkoxy-C1-C3-alkyl or C1-C3-alkylthio-C1-C3-alkyl,
R3 represents C1-C6-alkyl, C1-C6-alkoxy, C1-C3-alkoxy-C1-C3-alkyl, C1-C3-alkylthio-C1-C3-alkyl, C3-C6-cycloalkyl, phenyl or benzyl,
R4 represents hydrogen, C1-C6-a!kyl, C1-C4-alkylsulphinyl, C1-C4,-alkylsulphonyl, C1-C3-alkoxy-C1-C3-alkyl, C3-C6rcycloalkyi; C1-C4-haloalkyl, C1-C4-haloalkylthio, C1-C4-haloalkylsulphinyl, C1-C4-haloalkylsulphonyl, halo-C1-C3-alkoxy-C1-C3-alkyl, C3-C8-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms; forrnyl, formyl-C1-C3-alkyl, (C1-C3-alkyl)carbonyl-C1-C3-alkyl, (C1-C3-alkoxy)carbonyl-C1-C3-alkyl; halo-(C1-C3-alkyl)carbonyl-C1-C3-alkyl, halo-(C1-C3-alkoxy)carbonyl-C1-C3-alkyl having in each case 1 to 13 fluorine, chlorine and/or bromine atoms;
(C1-C6-alkyl)carbonyl, (C1-C4-alkoxy)carbonyl, (C1-C3-alkoxy-C1-C3-alkyl)carbonyl, (C3-C6-cycloalkyl)carbonyl; (C1-C4-haloalkyl)carbonyl, (C1-C4-haloalkoxy)carbonyl, (halo-C1-C3-alkoxy-C1-C3-alkyl)carbonyl, (C3-C6-halocycloalkyl)carbonyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms, or -C(=O)C(=O)R5, -CONR5R7 or -CH2NR8R9, R5 represents hydrogen, C1-C6-alkyl, C1-C4-alkoxy, C1-C3-alkoxy-C1-C3-alkyl, C3-C6-cycloalkyl; -C1-C4-haloalkyl, C1-C4-haloalkoxy, halo-C1-C3-alkoxy-C1-C3-alkyl, C3-C6-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R6 and R7 independently of one another each represent hydrogen, C1-C6-alkyl, C1-C3-alkoxy-C1-C3-alkyl, C3-C6-cycloalkyl; C1-C4-haloalkyl, halo-C1-C3-alkoxy-C1-C3-alkyl, C3-C6-halocycloalkyI having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R6 and R7 furthermore together with the nitrogen atom to which they are attached form a saturated heterocycle having 5 or 6 ring atoms which is optionally mono- to tetrasubstituted by identical or different substituents from the group consisting of halogen and C1-C4-alkyl, where the heterocycle may contain 1 or 2 further non-adjacent heteroatoms from the group consisting of oxygen, sulphur and NR10,
R8 and R9 independently of one another represent hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl; C1-C4-haloalkyl, C3-C6-halocycloalkyl having in each case 1 to 9 fluorine, chlorine and/or bromine atoms,
R8 and R9 furthermore together with the nitrogen atom to which they are attached form a saturated heterocycle having 5 or 6 ring atoms which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and C1-C4-alkyl, where the heterocycle may contain 1 or 2 further non-adjacent heteroatoms from the group consisting of oxygen, sulphur and NR10,
R10 represents hydrogen or C1-C4-alkyl,
A represents the radical of the formula (A2)
(Formula Removed)
(A2) in which R12 represents chlorine, iodine or dichioromethyl.
3. Process for preparing silylated carboxamides of the formula (1) as claimed in claim 1, wherein b) carboxylic acid derivatives of the formula (II)
(Formula Removed)
in which
X1 represents halogen or hydroxyl and
A is as defined in Claim 1
are reacted with amines of the formula (III)
(Formula Removed)
in which R, L, R1, R2, R3 and R4 are as defined in claim 1,
in the presence of a catalyst, in the presence of a condensing agent, in the presence of an
acid binder and in the presence of a diluent.
4. Compositions for controlling unwanted microorganisms, such as pathogenic fungi, bacteria, wherein they comprise 0.1 to 95 % of at least one silylated carboxamide of the formula (I) as claimed in claim 1, in addition to extenders and/or surfactants.

Documents:

2198-DELNP-2006-Abstract-(12-07-2010).pdf

2198-delnp-2006-abstract.pdf

2198-DELNP-2006-Claims-(12-07-2010).pdf

2198-DELNP-2006-Claims-(24-01-2011).pdf

2198-delnp-2006-claims.pdf

2198-DELNP-2006-Correspondence-Others-(12-07-2010).pdf

2198-DELNP-2006-Correspondence-Others-(24-01-2011).pdf

2198-DELNP-2006-Correspondence-Others-(25-01-2011).pdf

2198-delnp-2006-correspondence-others-1.pdf

2198-delnp-2006-correspondence-others.pdf

2198-delnp-2006-description (complete).pdf

2198-delnp-2006-form-1.pdf

2198-delnp-2006-form-18.pdf

2198-delnp-2006-form-2.pdf

2198-delnp-2006-form-3.pdf

2198-delnp-2006-form-5.pdf

2198-DELNP-2006-GPA-(12-07-2010).pdf

2198-DELNP-2006-GPA-(25-01-2011).pdf

2198-delnp-2006-gpa.pdf

2198-delnp-2006-pct-210.pdf

2198-delnp-2006-pct-304.pdf

abstract.jpg


Patent Number 247402
Indian Patent Application Number 2198/DELNP/2006
PG Journal Number 14/2011
Publication Date 08-Apr-2011
Grant Date 05-Apr-2011
Date of Filing 21-Apr-2006
Name of Patentee BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Applicant Address Alfred-Nobel-Str. 50, 40789 Monheim, Germany.
Inventors:
# Inventor's Name Inventor's Address
1 KARL-HEINZ KUCK, Pastor-Löh-Str. 30 a, 40764 Langenfeld, Germany.
2 RALF DUNKEL 9/11 RUE PIERRE DUPONT, 69001 LYON, FRANCE.
3 HANS-LUDWIG ELBE Dasnöckel 59, 42329 Wuppertal, Germany.
4 BENOIT HARTMANN, Färberstr. 1, 40764 Langenfeld, Germany.
5 ALEXANDER KLUSENER, Schiffsesweg 18, 50259 Pulheim, Germany.
6 JORG NICO GREUL, Am Sandberg 30a, 42799 Leichlingen, Germany.
7 ULRIKE WACHENDORFF-NEUMANN, Oberer Markenweg 85, 56566 Neuwied, Germany.
8 PETER DAHMEN, Altebrücker Str. 61, 41470 Neuss, Germany.
PCT International Classification Number C07F 7/08
PCT International Application Number PCT/EP2004/012590
PCT International Filing date 2004-11-06
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 103 54 607.3 2003-11-21 Germany